Subtype
Colon Neoplasm
CI-CAN-00004992Explore in graph →
Non-malignant271 active trials5 approved drugs17 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00004992Explore in graph →
Clinical trials
1,559 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03432806 | A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors | active not recruiting | — | 51 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT00996710 | Genomic Structural Variation in Cancer Susceptibility | active not recruiting | — | 1,275 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 4, 2025 |
| clinicaltrials |
| NCT04124406 | Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality | active not recruiting | — | 150,000 | Exact Sciences CorporationINDUSTRY | 1 | Oct 3, 2025 | clinicaltrials |
| NCT05163028 | A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations | active not recruiting | Phase 1 | 42 | HUYABIO International, LLC.INDUSTRY | 2 | Sep 24, 2025 | clinicaltrials |
| NCT05485974 | A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation | active not recruiting | Phase 1 | 44 | HUYABIO International, LLC.INDUSTRY | 2 | Sep 24, 2025 | clinicaltrials |
| NCT06124378 | Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer | active not recruiting | Phase 2 | 60 | First Affiliated Hospital of Guangxi Medical UniversityOTHER | 1 | Sep 24, 2025 | clinicaltrials |
| NCT03975491 | The Exercise And Colorectal Cancer Treatment Trial(EXACT) | active not recruiting | N/A | 60 | Pennington Biomedical Research CenterOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT04416490 | Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer(OCEAN) | active not recruiting | — | 2,013 | Boryung Pharmaceutical Co., LtdINDUSTRY | 1 | Sep 12, 2025 | clinicaltrials |
| NCT06728358 | The Future Management of Patients With Neoplasms of the Gastro-intestinal Tract(SOCRATE) | active not recruiting | N/A | 300 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 26, 2025 | clinicaltrials |
| NCT07137000 | The Effect of Art Therapy in Patients Undergoing Colorectal Cancer | active not recruiting | N/A | 96 | Saglik Bilimleri UniversitesiOTHER | 1 | Aug 22, 2025 | clinicaltrials |
| NCT07106463 | Microbiota: Its Role in Chronic Inflammation, IDB and Risk of Colorectal Cancer. Evaluation of a Predictive Prognostic Model With Therapeutic Implications | active not recruiting | — | 100 | University of MessinaOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT03694938 | Detection of Brain Metastasis by MRI in Metastatic Colorectal Cancer Patients | active not recruiting | N/A | 143 | Poitiers University HospitalOTHER | 1 | Jul 20, 2025 | clinicaltrials |
| NCT05551052 | CRC Detection Reliable Assessment With Blood(CRC-DRAW) | active not recruiting | — | 196 | New Day DiagnosticsNETWORK | 1 | May 29, 2025 | clinicaltrials |
| NCT04068103 | Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery | active not recruiting | Phase 2 / Phase 3 | 635 | NRG OncologyOTHER | 3 | May 7, 2025 | clinicaltrials |
| NCT04201717 | Intracorporeal Anastomosis Versus Extracorporeal Anastomosis for Left Colon Cancer | active not recruiting | N/A | 350 | Jilin UniversityOTHER | 1 | May 7, 2025 | clinicaltrials |
| NCT05179824 | Tempus Priority Study: A Pan-tumor Observational Study | active not recruiting | — | 1,000 | Tempus AIINDUSTRY | 1 | May 6, 2025 | clinicaltrials |
| NCT04713007 | Improving Quality of Life for Colon Cancer Patients and Their Caregivers | active not recruiting | N/A | 60 | University of HawaiiOTHER | 1 | Apr 27, 2025 | clinicaltrials |
| NCT03428477 | EPA for Metastasis Trial 2(EMT2) | active not recruiting | Phase 3 | 418 | Mark A Hull, PhD FRCPOTHER | 1 | Apr 18, 2025 | clinicaltrials |
| NCT06920082 | Progressive Muscle Relaxation Exercises on Sleep, Fatigue and Pain in Pancreatic and Colon Cancer Patients | active not recruiting | N/A | 60 | Istanbul Sabahattin Zaim UniversityOTHER | 1 | Apr 9, 2025 | clinicaltrials |
| NCT06443203 | Multimodal Prehabilitation in Colorectal Cancer Patients | active not recruiting | N/A | 112 | University Hospital of FerraraOTHER | 1 | Mar 30, 2025 | clinicaltrials |
| NCT03200834 | Comparison of D2 vs D3 Lymph Node Dissection for Right Colon Cancer (RICON) | active not recruiting | N/A | 239 | G.V. Bondar Republican Cancer CenterOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT06852495 | the Effect of Environmental Factors on Colorectal Cancer Based on Macrogenomes | active not recruiting | — | 200 | Dong PengOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT03255434 | LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy(LEANOX) | active not recruiting | Phase 2 | 160 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT04046445 | Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer(KISIMA-01) | active not recruiting | Phase 1 | 96 | Amal TherapeuticsINDUSTRY | 4 | Jan 29, 2025 | clinicaltrials |
| NCT05688280 | Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS(INJECTABL-1) | active not recruiting | Phase 1 / Phase 2 | 42 | Immunophotonics, Inc.INDUSTRY | 5 | Jan 8, 2025 | clinicaltrials |
| NCT05121038 | CEND-1 in Combination with Neoadjuvant FOLFIRINOX with or Without Panitumumab(CENDIFOX) | active not recruiting | Phase 1 / Phase 2 | 50 | Anup KasiOTHER | 1 | Dec 17, 2024 | clinicaltrials |
| NCT06709144 | Borderline of CME/D3 Dissection for Local Advanced Right-sided Colon Cancer(BLARCC) | active not recruiting | Phase 3 | 896 | Haixing Ju, MDOTHER | 1 | Nov 29, 2024 | clinicaltrials |
| NCT04294264 | TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer | active not recruiting | Phase 2 | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Nov 18, 2024 | clinicaltrials |
| NCT03464305 | ASPIRIN Trial Belgium(ASPIRIN) | active not recruiting | Phase 3 | 148 | University Hospital, AntwerpOTHER | 1 | Mar 19, 2024 | clinicaltrials |
| NCT02301286 | A Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients(ASPIRIN) | active not recruiting | Phase 3 | 770 | Leiden UniversityOTHER | 1 | Mar 18, 2024 | clinicaltrials |
| NCT04259398 | Anesthesia and Cancer Study: Colon Cancer | active not recruiting | N/A | 797 | Seoul National University HospitalOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT03089268 | Molecular and Histological Characteristics of Serrated Lesions of the Colon(SERRACOLON) | active not recruiting | — | 700 | Hospital Universitario La FeOTHER | 1 | Oct 2, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Dec 2, 2025source: clinicaltrials